Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ranolazine After Deferral of Percutaneous Coronary Intervention by Fractional Flow Reserve (IMWELL3)

NCT02147834 is registered in ClinicalTrials.gov with North Florida Foundation for Research and Education as lead sponsor.

NCT NCT02147834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02147834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ranolazine After Deferral of Percutaneous Coronary Intervention by Fractional Flow Reserve (IMWELL3)
Lead sponsor
North Florida Foundation for Research and Education
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2015
Completion date
September 30, 2016
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina